Summary
Metizolam is a research chemical with very little history of human use and minimal scientific study. It was patented in 1995 but never marketed as a medication. Due to its extreme potency, volumetric liquid dosing is strongly recommended to ensure accurate administration. Abrupt discontinuation after regular use is potentially life-threatening; users should taper their dose gradually over weeks under medical supervision if possible. Metizolam is illegal or controlled in many jurisdictions including Sweden, Germany, Switzerland, Turkey, and the United Kingdom.
Dose Information
| ROA | Light | Common | Strong | Heavy |
|---|---|---|---|---|
| Oral | 1-2mg | 2-4mg | 4-6mg | 6mg+ |
Light
Common
Strong
Heavy
Onset, Duration & After-effects
| ROA | Onset | Peak | Offset | After Effects | Total |
|---|---|---|---|---|---|
| Oral | 30-90 min | 30 min | 3-6 hrs | 10-30 hrs | 300-0 min |
Tolerance
Build-up
develops over 1–4 weeks of daily use; hypnotic tolerance faster than anxiolytic tolerance
Reset
weeks to months depending on half-life and duration of use; taper recommended
Effects
Positive
- Muscle Relaxation
- Muscle relaxation
- Physical euphoria
- Anxiolytic
Negative
- Respiratory Depression
- Motor impairment
- Respiratory depression
- Sedation
- Sedative
- Dystaxia
Positive
- Anxiety Suppression
- Dream Potentiation
- Cognitive Euphoria
Negative
- Motor Control Loss
- Amnesia
- Dizziness
- Thought Deceleration
- Emotion Suppression
- Delusions of Sobriety
- Compulsive Redosing
- Analysis Suppression
- Delusions
- Information processing suppression
Positive
- Increased libido
- Appetite enhancement
- Increased music appreciation
Negative
- Disinhibition
- Visual acuity suppression
- Acuity suppression
- Dehydration
- Light sensitivity
- Dulled perception
- Perception of bodily heaviness